Liver Disease
News
Panel calls new hepatitis C drug ‘low value’
News
Glycerol phenylbutyrate reduces hepatic encephalopathy events in cirrhosis
Major finding: Glycerol phenylbutyrate significantly reduces the number of cirrhosis patients experiencing hepatic encephalopathy and the time to...
News
Acute kidney dysfunction related to nonviral comorbidities in chronic HCV
Major finding: Acute kidney dysfunction was significantly more likely to develop in HCV patients who had comorbid diabetes (47.6% prevalence,...
News
Medicare proposes coverage for hepatitis C screening
From the AGA Journals
NASH liver transplant mortality differs from non-NASH
Major finding: Patients undergoing liver transplant for nonalcoholic steatohepatitis are at a greater risk for death due to sepsis and...
News
Pancytopenia warning added to label of hepatitis C drug boceprevir
News
Daclatasvir-sofosbuvir combo scores in resistant hepatitis C
Major finding: A total of 98% of patients with chronic HCV 1 and 91% of those with chronic HCV 2 or 3 achieved a sustained virologic response on...
News
New website provides guidance on treating hepatitis C, with regular updates
Commentary
The price and cost of hepatitis C treatment
News
Triple-antiviral therapy achieves 94% response without interferon, ribavirin
Major finding: By week 4, patients achieved a HCV-RNA level of less than 25 IU/mL; 97% maintained that level through the end of treatment.